Evidence map›Paper›PMID 35877225›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Evolution of a Systematic Approach to Smoking Cessation in Ontario's Regional Cancer Centres.

Erin Cameron, Vicki Lee, Sargam Rana, Mohammad Haque, Naomi Schwartz, Sahara Khan, Rebecca Truscott, Linda Rabeneck

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Integration of smoking cessation and lung cancer screening.Translational lung cancer research · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erin CameronPrevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Vicki LeePrevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Sargam RanaPrevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Mohammad HaquePrevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Naomi SchwartzPrevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Sahara KhanPrevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Rebecca TruscottPrevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Linda RabeneckPrevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smoking cessation after a cancer diagnosis can significantly improve a person's prognosis, treatment efficacy and safety, and quality of life. In 2012, Cancer Care Ontario (now part of Ontario Health) introduced a Framework for Smoking Cessation, to be implemented for new ambulatory cancer patients at the province's 14 Regional Cancer Centres (RCCs). Over time, the program has evolved to become more efficient, use data for robust performance management, and broaden its focus to include new patient populations and additional data collection. In 2017, the framework was revised from a 5As to a 3As brief intervention model, along with an opt-out approach to referrals. The revised model was based on emerging evidence, feedback from stakeholders, and an interim program evaluation. Results showed an initial increase in referrals to cessation services. Two indicators (tobacco use screening and acceptance of a referral) are routinely monitored as part of Ontario Health's system-wide performance management approach, which has been identified as a key driver of change among RCCs. Due to the COVID-19 pandemic, many RCCs reported a decrease in these indicators. RCCs that were able to maintain a high level of smoking cessation activities during the pandemic offer valuable lessons, including the opportunity to swiftly leverage virtual care. Future directions for the program include capturing data on cessation outcomes and expanding the intervention to new populations. A focus on system recovery from COVID-19 will be paramount. Smoking cessation must remain a core element of high-quality cancer care, so that patients achieve the best possible health benefits from their treatments.

Indexed as

COVID-19NeoplasmsNeoplasms, Second PrimarySmoking CessationHumansOntarioPandemicsQuality of Lifeperformance managementprogram implementationsmoking cessation

Identifiers

PMID35877225
PMCPMC9323297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.